Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioNano Genomics

Explore full profile

Next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data

San Diego, United StatesFounded 2003Biotech & Life Sciences
Valuation $15M Market cap · Aug/2026
Revenue $32M Latest reported FY

At a glance

Status
Listed
Founded
2003
Headquarters
San Diego, United States
Listing
IPO 2018
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Ben Franklin Technology Partners of Southeastern Pennsylvania
  • 21Ventures

Series A2 investors entered at this stage

  • Battelle Ventures
  • KT Venture Group

Series B and later8 investors entered at this stage

  • Gund Investment
  • Newzone Venture Capital
  • Princeton University
  • Domain Associates
  • Legend Capital
  • Monashee Capital Corp.
  • Novartis Venture Fund
  • Federated Hermes

Talent

Book a demo to see the people
Employees mapped 174 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 29 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown
Web traffic by country
15K monthly visits
across markets
🇺🇸 United States38.7%
🇨🇦 Canada18.7%
🇬🇧 United Kingdom12.7%
🇮🇳 India9.3%
🇪🇸 Spain8.7%
Top 5 markets shown

Investments and acquisitions

Disclosed deals where BioNano Genomics was the backer or acquirer, 2020–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across BioNano Genomics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        BioNano Genomics's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about BioNano Genomics on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See BioNano Genomics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles